Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep

Published byDevi Agusalim Modified over 5 years ago

Similar presentations

Presentation on theme: "Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep"— Presentation transcript:

1 Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep.2017.09.180
Prescription Indications Indications for wearable cardioverter-defibrillator prescription determined from primary chart review (n = 147). Listed are patients with primary prevention indications for cardiomyopathy with left ventricular ejection fraction (EF) ≤35% (red), secondary prevention (green), implantable cardioverter-defibrillator (ICD) explantation (blue), and patients otherwise felt to be at high sudden cardiac death risk (orange). ICM = ischemic cardiomyopathy; NICM = nonischemic cardiomyopathy. Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep 2017 American College of Cardiology Foundation

Download ppt "Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep"

Similar presentations

Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)

Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.
Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.

Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.
Date of download: 7/10/2016 From: Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial.

Date of download: 7/10/2016 From: Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator.
Figure 1 Study flow chart.

Figure 1 Study flow chart.
New Guidelines to Prevent SCD: What You Need to Know

New Guidelines to Prevent SCD: What You Need to Know
Tom F. Brouwer et al. JACEP 2016;2:89-96

Tom F. Brouwer et al. JACEP 2016;2:89-96
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial

Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)

DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.

Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
Volume 15, Issue 10, Pages e190-e252 (October 2018)

Volume 15, Issue 10, Pages e190-e252 (October 2018)
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Tom F. Brouwer et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:
Volume 15, Issue 10, Pages e73-e189 (October 2018)

Volume 15, Issue 10, Pages e73-e189 (October 2018)
Pablo Ávila et al. JACEP 2015;1:

Pablo Ávila et al. JACEP 2015;1:

Similar presentations

Ads by Google